approval · primary record
UBLITUXIMAB-XIIY
FDA · BLA · 2026-01-16
| Agency | FDA |
|---|---|
| Submission type | BLA |
| Action date | 2026-01-16 |
| Brand | BRIUMVI |
| Sponsor | TG THERAPEUTICS, INC |
| Route | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:42.454Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:UBLITUXIMAB-XIIY:2026-01-16
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.